| Description | Icaritin (Anhydroicaritin) has hormone regulation activity and cardiovascular function improvement activity. Icaritin has anticancer activity, can induce S phase arrest and apoptosis, inhibit ENKL cell proliferation. Icaritin has anti-multiple myeloma activity, mainly mediated by inhibiting IL-6/JAK2/STAT3 signaling. Icaritin at low concentration (4 or 8 μMol/L) can promote rat chondrocyte proliferation and inhibit cell apoptosis, while the effect of Icaritin on rat chondrocyte at high concentration was reversed. |
| Target activity | CML-CP:13.4 μM, CML-BC:18 μM, Proliferation (K562 cells):8 μM |
| Synonyms | Anhydroicaritin, 去水淫羊藿黄素, Cycloicaritin |
| molecular weight | 368.38 |
| Molecular formula | C21H20O6 |
| CAS | 118525-40-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 10 mg/mL (27.15 mM) H2O: < 1 mM (insoluble or slightly soluble) |
| References | 1. Zhu S, et al. Oncotarget. 2015 Apr 30;6(12):10460-72. 2. Qin L, et al. Biomaterials. 2015 Aug;59:125-43. 3. Liu YQ, et al. Phytomedicine. 2014 Oct 15;21(12):1633-7. 4. Gao Y, Xu G, Ma L, et al. Icarisid I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity[J]. Cell Communication and Signaling. 2020 5. Gao Y, Xu G, Ma L, et al. Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity[J]. Cell Communication and Signaling. 2021, 19(1): 1-14. |